Correlation Between Tff Pharmaceuticals and Inhibrx
Can any of the company-specific risk be diversified away by investing in both Tff Pharmaceuticals and Inhibrx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tff Pharmaceuticals and Inhibrx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tff Pharmaceuticals and Inhibrx, you can compare the effects of market volatilities on Tff Pharmaceuticals and Inhibrx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tff Pharmaceuticals with a short position of Inhibrx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tff Pharmaceuticals and Inhibrx.
Diversification Opportunities for Tff Pharmaceuticals and Inhibrx
0.55 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Tff and Inhibrx is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Tff Pharmaceuticals and Inhibrx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibrx and Tff Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tff Pharmaceuticals are associated (or correlated) with Inhibrx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibrx has no effect on the direction of Tff Pharmaceuticals i.e., Tff Pharmaceuticals and Inhibrx go up and down completely randomly.
Pair Corralation between Tff Pharmaceuticals and Inhibrx
Given the investment horizon of 90 days Tff Pharmaceuticals is expected to under-perform the Inhibrx. In addition to that, Tff Pharmaceuticals is 5.26 times more volatile than Inhibrx. It trades about -0.28 of its total potential returns per unit of risk. Inhibrx is currently generating about -0.03 per unit of volatility. If you would invest 1,580 in Inhibrx on September 2, 2024 and sell it today you would lose (54.00) from holding Inhibrx or give up 3.42% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Tff Pharmaceuticals vs. Inhibrx
Performance |
Timeline |
Tff Pharmaceuticals |
Inhibrx |
Tff Pharmaceuticals and Inhibrx Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Tff Pharmaceuticals and Inhibrx
The main advantage of trading using opposite Tff Pharmaceuticals and Inhibrx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tff Pharmaceuticals position performs unexpectedly, Inhibrx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibrx will offset losses from the drop in Inhibrx's long position.Tff Pharmaceuticals vs. Gain Therapeutics | Tff Pharmaceuticals vs. In8bio Inc | Tff Pharmaceuticals vs. Lantern Pharma | Tff Pharmaceuticals vs. INmune Bio |
Inhibrx vs. Crinetics Pharmaceuticals | Inhibrx vs. Merus BV | Inhibrx vs. Lyell Immunopharma | Inhibrx vs. Kronos Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Complementary Tools
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Equity Valuation Check real value of public entities based on technical and fundamental data |